Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00151489
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2005-09-07
Brief Title:
Safety and Efficacy Study of Pregabalin in Fibromyalgia
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
A Six-Month Double-Blind Placebo Controlled Durability of Effect Study of Pregabalin for Pain Associated With Fibromyalgia
Status:
COMPLETED
Status Verified Date:
2006-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research study of pregabalin and fibromyalgia is to see if 1 pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2 to see if different dosages work better reduce pain and mild to no side effects for different people
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None